B
efore the pandemic, AstraZeneca was highly regarded in the business and pharmaceutical world – seen as one of the UK’s best companies. Now, thanks to Britain’s successful vaccine programme, it is a household name.
SUBSCRIBE
Biohealth Innovation
Founding Member of
